Previous studies on the prognostic significance of SALL4 in GC are limited by their small sample size (103 cases), and the clinical significance of SALL4 has been evaluated exclusively at the mRNA level, rather than at the protein level (Liu J. et al., 2014). This evidence concerns the gene SALL4 and gastric cancer.